Clinical trial
Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation…
NCT00210106 · Institut Bergonié, Other · Completed
Key facts
| NCT number | NCT00210106 |
|---|---|
| Title | Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. |
| Official title | Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. A Phase 2 Study. |
| Acronym | ARF2003 |
| Lead sponsor | Institut Bergonié, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Device |
| Interventions | Ablathermy |
| Enrollment | 52 |
| Start date | Jun 1, 2003 |
| Primary completion | Dec 1, 2008 |
| Completion | May 1, 2010 |
| First posted | Sep 21, 2005 |
| Last update posted | May 18, 2021 |
| Countries | France |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: